Biopsy Devices Market Overview

A biopsy is carried out to diagnose any inflammatory conditions, infestations diseases, in case of organ transplantation, and for the evaluation of fertility. However, biopsy has gained traction in the cancer arena. A biopsy is the only definitive way to determine the presence of cancer. Oncology diseases are spreading at an alarming rate which has generated massive demand for screening. There is a huge demand for high-quality diagnostic processes, especially huge unmet needs in the emerging economies of the world create a conducive environment for the growth of the global Biopsy Devices Market.

A Biopsy is performed to obtain a piece of tissue or a sample of cells from a patient’s body. Biopsy devices such as Biopsy Needles, biopsy needles, forceps, biopsy guidance system, and others are used for the same. The Global Biopsy Devices Market Share. is anticipated to scale to a valuation of USD 2.4 Bn at a CAGR of 6.80% by the end of the forecast period of 2022-2030, as per a recent study by Market Research Future (MRFR).

Minimally invasive biopsies have replaced open surgical excisional biopsy in patients which has not only reduced costs but also reduced the psychological burden affecting patients. This has encouraged patients to undergo biopsy procedures and in turn, induced demand within the global biopsy devices market Insights. Furthermore, technological advancement in biopsy devices has led to the development of improved and automated biopsy devices which can even be used with greater ease and less expertise. Also, safety quotient is also increased in automated biopsy devices.

Competitive Landscape

 Global Biopsy Devices Market Players include Focal Therapeutics, Inc., C. R. Bard, Inc. Creganna, Scion Medical Technologies, LLC. (UK), BD, Integra LifeSciences Corporation, Hologic, Inc., Argon Medical Devices, Inc., Precision Biopsy, LLC, Cook Medical, and Leica Biosystems.

Market Segmentation

The Global Biopsy Devices Market Outlook has been segmented based on product type, application, and end user.

By product type, the global biopsy devices market has been segmented into biopsy guns, biopsy guidance system, biopsy needles, forceps, and others.

By application, the market has been segmented into bone marrow biopsy, surgical biopsy, skin biopsy, needle biopsy, Cancer Diagnosis, and others.

By end user, market has been segmented into hospitals, specialty clinics, diagnostic centers, academic research institutes, and others.

Regional Analysis

North America biopsy devices market Trends is expected to hold the grand share of the global market. Europe market can secure the second position globally. Asia Pacific market can surge at a high pace. The availability of firm medical infrastructure can bolster the expansion of the biopsy device market across the study period. Hectic work-life schedule, consumption of poor diet, genetics, and environmental factors are chief cause for the high prevalence of cancer in the region. These are creating several growth opportunities for the expansion of the regional market. Europe boasting of the easy availability of experts that can handle biopsy devices can prompt the expansion of the regional market in near future. Expansion of ageing populace and high prevalence of cancer in APAC can support the growth of the market across the assessment period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]